NYSE:BLCOMedical Equipment
Bausch + Lomb (BLCO) Study Shows XIIDRA Eye Drops Improve Comfort For Contact Lens Wearers
Bausch + Lomb (BLCO) recently announced positive results from a study on XIIDRA, enhancing its position in treating dry eye disease in contact lens wearers. This news, alongside the U.S. launch of ASANA gas permeable lenses and improved Q2 earnings with revised revenue guidance, coincided with a 22% share price increase over the last quarter. While these developments likely supported the share price, it's worth noting that the broader market also experienced a positive trend, with indexes...